Evidence map›Paper›PMID 32344843›Full record

ArticlePathogens (Basel, Switzerland)2020

Magdalena Pajor, Zirui Ray Xiong, Randy W Worobo, Piotr Szweda

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Differential impact ofHeliyon · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Magdalena PajorDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, G. Narutowicza Street 11/12, 80-233 Gdansk, Poland.ORCID 0000-0002-1980-0732
Zirui Ray XiongDepartment of Food Science, Cornell University, Stocking Hall, Ithaca, NY 14853-7201, USA.
Randy W WoroboDepartment of Food Science, Cornell University, Stocking Hall, Ithaca, NY 14853-7201, USA.
Piotr SzwedaDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, G. Narutowicza Street 11/12, 80-233 Gdansk, Poland.
Cornell University · USGdańsk University of Technology · PL

Funding

Multi-state grant - Cornell University S1077Narodowym Centrum Nauki 2015/18/E/NZ6/00700
6 · The paper itself

Abstract

An emerging need for new classes of antibiotics is, on the one hand, evident as antimicrobial resistance continues to rise. On the other hand, the awareness of the pros and cons of chemically synthesized compounds' extensive use leads to a search for new metabolites in already known reservoirs. Previous research showed that

Indexed as

antimicrobial activityantimicrobial compoundsantimicrobial peptidesEscherichia coliListeria monocytogenesPaenibacillus alveiStaphylococcus aureus

Identifiers

PMID32344843
PMCPMC7281493
OpenAlexW3019426567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.